Cargando…

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver disease in the Western world, probably due to the growing prevalence of obesity, metabolic diseases, and exposure to some environmental agents. In certain patients, simple hepatic steatosis can progress to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juanola, Oriol, Martínez-López, Sebastián, Francés, Rubén, Gómez-Hurtado, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155932/ https://www.ncbi.nlm.nih.gov/pubmed/34069012 http://dx.doi.org/10.3390/ijerph18105227

Ejemplares similares

Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
por: Wajsbrot, Natalia Balassiano, et al.
Publicado: (2022)

Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis
por: Caparrós, Esther, et al.
Publicado: (2020)

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2021)

Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short‐Chain Fatty Acids in Experimental Cirrhosis
por: Juanola, Oriol, et al.
Publicado: (2018)

Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022)

Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
por: Sun, Chao, et al.
Publicado: (2015)

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life
por: Carol, Marta, et al.
Publicado: (2022)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Hagiwara, Satoru, et al.
Publicado: (2021)

Bacterial Translocation as Inflammatory Driver in Crohn’s Disease
por: Linares, Raquel, et al.
Publicado: (2021)

Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
por: Meroni, Marica, et al.
Publicado: (2018)

MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients
por: Gouda, Weaam, et al.
Publicado: (2017)

Paneth Cells Regulate Lymphangiogenesis under Control of Microbial Signals during Experimental Portal Hypertension
por: Hassan, Mohsin, et al.
Publicado: (2022)

Association of Genetic and Environmental Factors with Non-Alcoholic Fatty Liver Disease in a Chinese Han Population
por: Li, Zheng, et al.
Publicado: (2020)

Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
por: Lee, Joo Ho, et al.
Publicado: (2014)

Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2019)

Role of Leptin in Non-Alcoholic Fatty Liver Disease
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients
por: Belinchón-Romero, Isabel, et al.
Publicado: (2021)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Transcriptional and Epigenetic Alterations in the Progression of Non-Alcoholic Fatty Liver Disease and Biomarkers Helping to Diagnose Non-Alcoholic Steatohepatitis
por: Zhu, Yalan, et al.
Publicado: (2023)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
por: Martínez–Sánchez, Celia, et al.
Publicado: (2023)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Metabolic profiling of adolescent non-alcoholic fatty liver disease
por: Hartley, April, et al.
Publicado: (2019)

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis
por: Pan, Qin, et al.
Publicado: (2023)

Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
por: Gitto, Stefano, et al.
Publicado: (2016)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome
por: Abbate, Manuela, et al.
Publicado: (2021)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2022)

Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011)

Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
por: Yu, Jae Young, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease: a narrative review of genetics
por: Danford, Christopher J., et al.
Publicado: (2018)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
por: Martin, Katherine, et al.
Publicado: (2021)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome
por: Mousavi, Zohreh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u112gp7i0go2948gm7sec1jeqb